Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence True

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Urology|December 11, 2003
Why we must better understand neuroendocrine differentiation in prostate cancerLawrence True
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Immunohistochemical validation of expression microarray resultsLawrence True, Ziding Feng
Brain Pathology (Zurich, Switzerland)|September 11, 2008
70-year-old man with enlarged pineal glandBonnie Cole, Thomas J Montine, Lawrence True, et al.
Cancer|June 20, 2007
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk featuresMichael Dattoli, Kent Wallner, Lawrence True, et al.
Cancer|February 6, 2003
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphataseMichael Dattoli, Kent Wallner, Lawrence True, et al.
Urology|October 11, 2003
Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapyDaniel Reed, Kent Wallner, Gregory Merrick, et al.
Urology|February 27, 2007
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extensionMichael Dattoli, Kent Wallner, Lawrence True, et al.
Expert Review of Molecular Diagnostics|March 4, 2006
Multicolor quantum dots for molecular diagnostics of cancerAndrew M Smith, Shivang Dave, Shuming Nie, et al.
Urology|August 1, 2022
Prostate-specific Antigen (PSA) Screening and a Lifesaving Cardiac TransplantDiboro Kanabolo, Lawrence True, Funda Vakar-Lopez, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trialKent Wallner, Gregory Merrick, Lawrence True, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Urology|December 11, 2003
Why we must better understand neuroendocrine differentiation in prostate cancerLawrence True
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Immunohistochemical validation of expression microarray resultsLawrence True, Ziding Feng
Brain Pathology (Zurich, Switzerland)|September 11, 2008
70-year-old man with enlarged pineal glandBonnie Cole, Thomas J Montine, Lawrence True, et al.
Cancer|June 20, 2007
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk featuresMichael Dattoli, Kent Wallner, Lawrence True, et al.
Cancer|February 6, 2003
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphataseMichael Dattoli, Kent Wallner, Lawrence True, et al.
Urology|October 11, 2003
Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapyDaniel Reed, Kent Wallner, Gregory Merrick, et al.
Urology|February 27, 2007
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extensionMichael Dattoli, Kent Wallner, Lawrence True, et al.
Expert Review of Molecular Diagnostics|March 4, 2006
Multicolor quantum dots for molecular diagnostics of cancerAndrew M Smith, Shivang Dave, Shuming Nie, et al.
Urology|August 1, 2022
Prostate-specific Antigen (PSA) Screening and a Lifesaving Cardiac TransplantDiboro Kanabolo, Lawrence True, Funda Vakar-Lopez, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trialKent Wallner, Gregory Merrick, Lawrence True, et al.
Pageof 6